RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
  • Regulatory NewsRegulatory News

    2016 CMS Data on Industry Payments to US Physicians, Hospitals: Company Breakdowns

    The US Centers for Medicare and Medicaid Services (CMS) on Friday released 2016 data on more than $8 billion in payments (which is on par with 2015 data) made by 1,481 pharmaceutical, biotech and medical device companies to more than 600,000 physicians and 1,146 hospitals. In total, CMS calculated that $2.8 billion was spent on general payments and $4.36 billion on research payments.  In its breakdown of the numbers, CMS says that more than $1 billion in 2016 was s...
  • Regulatory NewsRegulatory News

    Doctors Without Borders Appeals Exclusive License Granted to Sanofi for Zika Vaccine

    Doctors Without Borders (MSF) on Friday appealed the US Department of Defense’s decision to grant an exclusive, royalty-bearing license to Sanofi Pasteur for patents to a Zika vaccine developed with US government funds. "MSF objects to the granting of an exclusive patent license on a U.S. government-funded invention to a single pharmaceutical company as well as to the lack of conditions to ensure the vaccine will be appropriately developed and made available and ...
  • Regulatory NewsRegulatory News

    Doctors Without Borders: Asian Trade Deal Could Restrict Access to Affordable Generics

    The Regional Comprehensive Economic Partnership (RCEP) trade agreement is kicking off another round of negotiations on Sunday in Australia and Doctors Without Borders (MSF) is raising concerns about the tougher intellectual property rights that could restrict access to affordable generic drugs for many in Indonesia, Thailand, Myanmar, Cambodia and Laos. The Regional Comprehensive Economic Partnership (RCEP) is a proposed free trade agreement (FTA) between the ten member...
  • Regulatory NewsRegulatory News

    MSF: Access to New TB Medicines Falters Despite Conditional Approvals

    Doctors without Borders (MSF) released a new report on Monday offering details on how the first new drugs in nearly half a century were conditionally approved to treat tuberculosis (TB),  though only 2% of the roughly 150,000 who could benefit from these treatments have access to them. The report comes as the World Health Organization (WHO) reports that only half of notified multi-drug-resistant tuberculosis (MDR-TB) patients were successfully treated and cured in 2014 ...
  • Under Fire, Abbott Suspends Marketing Program in India

    • 17 October 2012
    Officials with Abbott Laboratories have announced the suspension of a controversial policy that has stoked controversy with critics who claim the company is buying favors from prescribing physicians by lavishing them with valuable gifts, reports Reuters . In an email obtained by the news organization, Abbott Healthcare, a subsidiary of its North American counterpart, said it would henceforth only distribute approved literature to prescribing physicians. "No brand ...
  • After Counterfeit Avastin Infiltrates Supply Chain, FDA Goes After Doctors

    The US Food and Drug Administration (FDA) is going after doctors in an attempt to protect the pharmaceutical supply chain from more instances of counterfeit medicines, reports Medscape News . There have been two instances of fake Avastin being found in the US in 2012-one in early April and another in mid-February . Both cases involved doctors deviating from approved suppliers to purchase Avastin from unauthorized wholesalers. While FDA Commissioner Margaret Hamburg ...
  • Study: Poorly Written Medication Warnings Missed by Busy Doctors

    • 30 March 2012
    A new study conducted by the US Department of Veterans Affairs and the Indianapolis-based Regenstrief Institute has found medication alerts are overly-detailed, poorly targeted and often skipped over by busy doctors, reports Fierce Health IT . The study, published in the International Journal of Medical Informatics , followed 30 doctors, nurse practitioners and pharmacists. That group received 320 medication alerts-which are used to alert medical professionals to new s...